As a mage, I just want to pursue the truth

Chapter 121 Ownership of the Demon Brain
India has allowed its pharmaceutical companies to produce generic drugs at the national level, and this has not changed even after joining the WTO.

As soon as Ke Chuang Bio's endorphin came out, Indian pharmaceutical companies tried to imitate it.

However, according to Zheng Li's endorphin paper published in Nature, the production process is very expensive and not cost-effective at all.

Asan has been trying to develop a large-scale industrial production method based on the laboratory production method of endorphins.

Before they could figure out the reason, Ke Chuang Bio started cooperating with pharmaceutical companies around the world. You pay the patent licensing fee, I will tell you the preparation method, and allow you to use my method to produce endorphins.

In fact, the interests of Indian pharmaceutical companies are deeply intertwined with those of European and American pharmaceutical companies. Some experiments that are inconvenient to conduct will be carried out in India. The specific reasons are also very simple.

Therefore, after the patent of KeChuang Biological was opened, Asan obtained the industrial production method and began to prepare endorphins on a large scale.

Their costs are similar to those of Sinovation Biotech, and are 50 percent lower than other pharmaceutical companies that have to pay patent licensing fees.

Endorphins produced by India are very popular in underdeveloped areas because they are cheap.

Ke Chuang Biotechnology can't do anything to them.

So much so that when Kechuang Biotechnology reflected internally later, it often brought up this case. When deciding to license the patent, no one thought of Ah San's behavior.

Although Cheng Gang is a veteran in the biopharmaceutical industry, there are very few innovative drugs in China, and almost none of them can be imitated by India.

Later, when we reviewed the situation internally, we all agreed that since we were not short of cash at the time, we should not have been in a hurry to license out the technology patents.

The current vice president of innovative drugs at Kechuang Bio has always said that the reverse engineering resistance of drug development must be taken into account during drug development to avoid being easily copied by Indian companies.

Turning back to Science and Technology Biotechnology, the significance of super batteries lies in their usage.

New energy vehicles will set off a new wave worldwide, and the squeeze on gasoline-powered vehicles will be more obvious.

But the source of energy has not changed in essence. Super batteries still need to be charged, and charging also requires energy from thermal power, hydropower, nuclear power and other methods.

Unlike the doubling of the conversion rate of crystalline silicon photovoltaic cells, photovoltaic power generation will completely replace thermal power generation and fundamentally solve the energy problem.

Of course, even if the conversion rate of photovoltaic cells is doubled, the cost of large-scale industrial production must be considered. If the cost is too high, it will be difficult to replace thermal power generation.

For the Blue Planet, controlled nuclear fusion is theoretically the best path.

Just twenty years ago, a popular science magazine said that controlled nuclear fusion was still fifty years away, and it seems like it's still fifty years away now.

In recent years, the progress seems to have indeed accelerated. China's sun broke the world record, burning at 1.2 million degrees Celsius for 101 seconds.

However, the estimate that it will take fifty years for controlled nuclear fusion to move from the laboratory to grid-connected power generation is optimistic.

The A-share market was closed after the meeting.

Ke Chuang Bio's weekly board meeting is held on Fridays. It will only be held if there is an agenda item. If there is no agenda item, it will be postponed to a later date.

Cheng Gang knew he only had two days. The news of the successful development of the Kechuang Bio-Super Battery would surely spread quickly. He knew his subordinates well.

Even if executives are not familiar with capital operations, after experiencing the history of Ke Chuang Bio's listing to today, they must have various channels to obtain knowledge related to capital operations.

People are profit-seeking, and some of the executives will inevitably collude with the institutions to take advantage of the opportunity to make a profit. Cheng Gang judged others by his own experience and knew that this was inevitable.

Fortunately, he had two days to operate.

And Zheng Li’s super sample has not arrived yet, so the market response will not be too strong.

Kechuang Biotechnology, a company engaged in brain-computer connection and biomedicine, suddenly claimed that it had developed a super battery. The credibility is questionable.

If CATL advertises like this, there will definitely be a strong response in the market, which will be enough to lead the lithium battery sector to a surge in daily limit prices.

Kechuang Biotechnology has a high reputation and weight, but not in the field of lithium batteries. Kechuang Biotechnology has no achievements in the field of lithium batteries to prove itself.

Even Cheng Gang himself doubted whether the specific effect of the super battery was really as Zheng Li said.

However, he can find a good agency to cooperate with in advance, and the results may not necessarily be as expected.

Even if it is just a small technical breakthrough, you can use the news to reap the benefits.

Of course, if the lithium metal positive electrode is really as Zheng Li said, then it is not just cutting leeks, it is called early value investment.

China's new energy vehicle companies will surely take advantage of this opportunity to gain ground and even have hope of occupying a large overseas market.

Among the new domestic car manufacturers, NIO has entered the Norwegian market for more than a year and released a Norwegian strategy in 21.

As a result, two months later, in the whole month of July, NIO sold two cars in Norway, while Xpeng sold 31 cars in Norway without making a big fanfare.

Ford, the best-selling car of the month, sold 898 units.

If supported by super batteries, domestic new energy will at least have its own core advantages in overseas markets.

The only problem here is that if Kechuang Bio's super battery technology is only open to Chinese car companies, it will definitely not escape the antitrust investigation of the European Union.

Cheng Gang did not raise this question at the meeting. He planned to have a good talk with Zheng Li in private.

In his opinion, if Ke Chuang Biotechnology wants to become a multinational giant, it must not only consider the Chinese market.

Including brain-computer connection technology, they just need to pay the fine, since the fine is paid by the mobile phone manufacturers anyway. The European Union cannot confiscate all their profits, but the most likely possibility is to confiscate a certain percentage of the patent licensing fees in the European market.

Cheng Gang thought that it was better than making no money at all, and what was more important was to expand the influence of Kechuang Bio in Europe.

So that the future brain-computer connection VR can be sold in Europe. Europe and the United States are the most important sources of income for independent games.

If brain-computer connected VR wants to create a new ecosystem, the European Union is an important market.

Cheng Gang felt that Zheng Li was young and hot-headed, so he planned to persuade him based on business logic.

While differences arose within Kechuang Biotechnology over the development path, Neon and England finally reached an agreement.

England paid certain political interests and obtained the right to use the magic brain, while the ownership of the magic coin is in the hands of Japan, and Japan must participate in the use of the magic brain throughout the process.

They want to know who used the magic brain.

England did not hesitate too much and chose to give the first magic brain to Wiles, who proved Fermat's Last Theorem.

As for why, until now, they have all been used by scientists and not by politicians.

It was because of the backdoor. It was some kind of consensus without evidence that Merlin had left a backdoor in the demon brain.

What if the politicians were injected with the magic brain and then controlled by Merlin, or even had their memories read remotely?
Even further, Merlin can turn memories into pictures and then publicize them?

There are too many uncontrollable risks.

(End of this chapter)